MeSH D015228 - hypertriglyceridemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D015228:
Hypertriglyceridemia
Events Timeline
No data
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| 3M | Fenofibrate | Duraprep | 2006-09-29 | |||
| Fenofibrate, Chlorhexidine | Soluprep | 2029-07-26 | 2018-08-08 | |||
| AbbVie | Niacin | Niaspan Titration Starter Pack | 1997-07-28 | |||
| Fenofibrate | Tricor | 1993-12-31 | $606 M | Q3/12-Q3/13 | ||
| Accord Healthcare | Atorvastatin | Atorvastatin | 2018-03-30 | |||
| Pravastatin | Pravastatin | 2016-11-17 | ||||
| Rosuvastatin | Rosuvastatin | 2016-10-31 | ||||
| Simvastatin | Simvastatin | 2008-02-26 | ||||
| Agnitio | Atorvastatin | Atorvastatin | 2021-09-02 | |||
| Ajanta Pharma | Fenofibrate | Fenofibrate | 2018-07-23 | |||
| Alembic Pharmaceuticals | Fenofibrate | Fenofibrate | 2019-08-09 | |||
| Alkem Laboratories | Atorvastatin | Atorvastatin | 2018-12-21 | |||
| Ezetimibe, Simvastatin | Ezetimibe Simvastatin | 2017-12-22 | ||||
| Rosuvastatin | Rosuvastatin | 2017-03-21 | ||||
| Allergan | Clofibrate | Clofibrate | 1987-09-18 | |||
| Ezetimibe, Simvastatin | Ezetimibe Simvastatin | 2017-04-26 | ||||
| Gemfibrozil | Gemfibrozil | 1994-10-24 | ||||
| Lovastatin | Lovastatin | 2001-12-17 | ||||
| Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine | Mvc | 1985-08-08 | ||||
| Niacin | Niacin | 1982-01-01 | ||||
| Pravastatin | Pravastatin | 2006-10-23 | ||||
| Rosuvastatin | Rosuvastatin | 2016-04-29 | ||||
| Simvastatin | Simvastatin | 2006-12-20 | ||||
| Althera Pharmaceutical | Ezetimibe, Rosuvastatin | Roszet | 2033-05-01 | 2021-03-23 | ||
| Amneal Pharmaceuticals | Ezetimibe, Simvastatin | Ezetimibe Simvastatin | 2017-11-21 | |||
| Fenofibrate | Fenofibrate | 2018-03-19 | ||||
| Niacin | Niacin | 2015-07-24 | ||||
| Rosuvastatin | Rosuvastatin | 2018-10-16 |
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
56%10/18
Phase 2
55%6/11
Phase 3
75%24/32
Approved: 16Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use